Item Type | Name |
Concept
|
Interleukin-1 Receptor Accessory Protein
|
Concept
|
Receptors, Interleukin-10
|
Concept
|
Interleukin-1
|
Concept
|
Interleukin 1 Receptor Antagonist Protein
|
Concept
|
Interleukin-10
|
Concept
|
Receptors, Interleukin-1
|
Concept
|
Receptors, Interleukin-4
|
Concept
|
Interleukin-13
|
Concept
|
Receptors, Interleukin-6
|
Concept
|
Interleukin-1beta
|
Concept
|
Receptors, Interleukin-2
|
Concept
|
Receptors, Interleukin-1 Type I
|
Concept
|
Interleukin-4
|
Concept
|
Interleukin-6
|
Concept
|
Receptors, Interleukin
|
Concept
|
Interleukin-18
|
Concept
|
Receptors, Interleukin-1 Type II
|
Concept
|
Interleukin-2
|
Concept
|
Interleukin-3
|
Academic Article
|
Different receptor mechanisms mediate the pyrogenic and behavioral effects of interleukin 1.
|
Academic Article
|
Effects of lipopolysaccharide on food-motivated behavior in the rat are not blocked by an interleukin-1 receptor antagonist.
|
Academic Article
|
Chronic intracerebral infusions of vasopressin and vasopressin antagonist modulate behavioral effects of interleukin-1 in rat.
|
Academic Article
|
Peripheral administration of lipopolysaccharide induces the expression of cytokine transcripts in the brain and pituitary of mice.
|
Academic Article
|
Synergy between tumor necrosis factor alpha and interleukin-1 in the induction of sickness behavior in mice.
|
Academic Article
|
Lipopolysaccharide and interleukin-1 depress food-motivated behavior in mice by a vagal-mediated mechanism.
|
Academic Article
|
Endogenous glucocorticoids down regulate central effects of interleukin-1 beta on body temperature and behaviour in mice.
|
Academic Article
|
Central mediation of the effects of interleukin-1 on social exploration and body weight in mice.
|
Academic Article
|
Hypersensitivity of lurcher mutant mice to the depressing effects of lipopolysaccharide and interleukin-1 on behaviour.
|
Academic Article
|
Expression and localization of p80 and p68 interleukin-1 receptor proteins in the brain of adult mice.
|
Academic Article
|
Early depressive symptoms in cancer patients receiving interleukin 2 and/or interferon alfa-2b therapy.
|
Academic Article
|
Role of IL-6 in cytokine-induced sickness behavior: a study with IL-6 deficient mice.
|
Academic Article
|
Interleukin-1 signaling in mouse astrocytes involves Akt: a study with interleukin-4 and IL-10.
|
Academic Article
|
The vagus nerve mediates behavioural depression, but not fever, in response to peripheral immune signals; a functional anatomical analysis.
|
Academic Article
|
IL-10 and IL-4 regulate type-I and type-II IL-1 receptors expression on IL-1 beta-activated mouse primary astrocytes.
|
Academic Article
|
Central injection of interleukin-13 potentiates LPS-induced sickness behavior in rats.
|
Academic Article
|
IL-1beta-mediated innate immunity is amplified in the db/db mouse model of type 2 diabetes.
|
Academic Article
|
A role of IL-1 in MPTP-induced changes in striatal dopaminergic and serotoninergic transporter binding: clues from interleukin-1 type I receptor-deficient mice.
|
Academic Article
|
Effects of interleukin-1 receptor antagonist on the behavioral effects of lipopolysaccharide in rat.
|
Academic Article
|
Sickness behavior as a new target for drug development.
|
Academic Article
|
Interleukin-1 induces conditioned taste aversion in rats: a possible explanation for its pituitary-adrenal stimulating activity.
|
Academic Article
|
Differential effects of IL-1ra on sickness behavior and weight loss induced by IL-1 in rats.
|
Academic Article
|
Expression of type I and type II interleukin-1 receptors in mouse brain.
|
Academic Article
|
Sickness behavior in birds caused by peripheral or central injection of endotoxin.
|
Academic Article
|
Growth hormone, growth factors and hematopoiesis.
|
Academic Article
|
Dual expression of p80 type I and p68 type II interleukin-I receptors on anterior pituitary cells synthesizing growth hormone.
|
Academic Article
|
Stress downregulates lipopolysaccharide-induced expression of proinflammatory cytokines in the spleen, pituitary, and brain of mice.
|
Academic Article
|
Vagotomy blocks behavioural effects of interleukin-1 injected via the intraperitoneal route but not via other systemic routes.
|
Academic Article
|
Systemic capsaicin pretreatment fails to block the decrease in food-motivated behavior induced by lipopolysaccharide and interleukin-1beta.
|
Academic Article
|
IL-4 and insulin-like growth factor-I inhibit the decline in Bcl-2 and promote the survival of IL-3-deprived myeloid progenitors.
|
Academic Article
|
Blockade of brain type II interleukin-1 receptors potentiates IL1beta-induced anorexia in mice.
|
Academic Article
|
Interleukin-1beta-converting enzyme-deficient mice resist central but not systemic endotoxin-induced anorexia.
|
Academic Article
|
Interleukin-4 and interleukin-10 regulate IL1-beta induced mouse primary astrocyte activation: a comparative study.
|
Academic Article
|
Central injection of IL-10 antagonizes the behavioural effects of lipopolysaccharide in rats.
|
Academic Article
|
Cholecystokinin receptors do not mediate the suppression of food-motivated behavior by lipopolysaccharide and interleukin-1 beta in mice.
|
Academic Article
|
Production of interleukin-1 receptor antagonist isoforms by microglia in mixed rat glial cells stimulated by lipopolysaccharide.
|
Academic Article
|
Chronic treatment with the atypical antidepressant tianeptine attenuates sickness behavior induced by peripheral but not central lipopolysaccharide and interleukin-1beta in the rat.
|
Academic Article
|
Characterization of interleukin-1 receptor antagonist isoform expression in the brain of lipopolysaccharide-treated rats.
|
Academic Article
|
How the immune and nervous systems interact during disease-associated anorexia.
|
Academic Article
|
Interleukin-10 in the brain.
|
Academic Article
|
Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy.
|
Academic Article
|
Long-term modulation of glucose utilization by IL-1 alpha and TNF-alpha in astrocytes: Na+ pump activity as a potential target via distinct signaling mechanisms.
|
Academic Article
|
Time-course of the expression of inflammatory cytokines and matrix metalloproteinases in the striatum and mesencephalon of mice injected with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, a dopaminergic neurotoxin.
|
Academic Article
|
Nuclear factor kappaB nuclear translocation as a crucial marker of brain response to interleukin-1. A study in rat and interleukin-1 type I deficient mouse.
|
Academic Article
|
Chronic psychosocial stress down-regulates central cytokines mRNA.
|
Academic Article
|
Interleukin-1beta mediates the memory impairment associated with a delayed type hypersensitivity response to bacillus Calmette-Gu?rin in the rat hippocampus.
|
Academic Article
|
IL-1beta impairs insulin-like growth factor i-induced differentiation and downstream activation signals of the insulin-like growth factor i receptor in myoblasts.
|
Academic Article
|
Cytokine production by spleen cells after social defeat in mice: activation of T cells and reduced inhibition by glucocorticoids.
|
Academic Article
|
Proinflammatory cytokine impairment of insulin-like growth factor I-induced protein synthesis in skeletal muscle myoblasts requires ceramide.
|
Academic Article
|
Inactivation of the cerebral NFkappaB pathway inhibits interleukin-1beta-induced sickness behavior and c-Fos expression in various brain nuclei.
|
Academic Article
|
Cellular distribution of interleukin-1alpha-immunoreactivity after MPTP intoxication in mice.
|
Academic Article
|
Inhibition of vagally mediated immune-to-brain signaling by vanadyl sulfate speeds recovery from sickness.
|
Academic Article
|
Novel activity of an anti-inflammatory cytokine: IL-10 prevents TNFalpha-induced resistance to IGF-I in myoblasts.
|
Academic Article
|
Regulation of IGF-I function by proinflammatory cytokines: at the interface of immunology and endocrinology.
|
Academic Article
|
Microglial/macrophage GRK2 determines duration of peripheral IL-1beta-induced hyperalgesia: contribution of spinal cord CX3CR1, p38 and IL-1 signaling.
|
Academic Article
|
HIV-1 Tat activates indoleamine 2,3 dioxygenase in murine organotypic hippocampal slice cultures in a p38 mitogen-activated protein kinase-dependent manner.
|
Academic Article
|
Interleukin-1 mediates behavioural but not metabolic effects of tumor necrosis factor alpha in mice.
|
Academic Article
|
Behavioural effects of peripherally injected interleukin-1: role of prostaglandins.
|
Academic Article
|
Compared effects of cold ambient temperature and cytokines on macronutrient intake in rats.
|
Academic Article
|
Corticosterone regulates behavioral effects of lipopolysaccharide and interleukin-1 beta in mice.
|
Academic Article
|
Molecular identification of two types of interleukin-1 receptors in the murine pituitary gland.
|
Academic Article
|
[Neurotropic effects of cytokines: at the limits of immunology and neurobiology].
|
Academic Article
|
Reduction in food and water intake induced by microinjection of interleukin-1 beta in the ventromedial hypothalamus of the rat.
|
Academic Article
|
Lipopolysaccharide induces sickness behaviour in rats by a vagal mediated mechanism.
|
Academic Article
|
Mechanisms of sickness-induced decreases in food-motivated behavior.
|
Academic Article
|
Effects of lipopolysaccharide and glucocorticoids on expression of interleukin-1 beta converting enzyme in the pituitary and brain of mice.
|
Academic Article
|
Vagotomy attenuates behavioural effects of interleukin-1 injected peripherally but not centrally.
|
Academic Article
|
Central lipopolysaccharide elevates plasma IL-6 concentration by an alpha-adrenoreceptor-mediated mechanism.
|
Academic Article
|
Interleukin-1-induced sickness behavior depends on behavioral lateralization in mice.
|
Academic Article
|
Brain type I but not type II IL-1 receptors mediate the effects of IL-1 beta on behavior in mice.
|
Academic Article
|
Cytokines and sickness behavior.
|
Academic Article
|
Biological activity and brain actions of recombinant rat interleukin-1alpha and interleukin-1beta.
|
Academic Article
|
Temporal and spatial relationships between lipopolysaccharide-induced expression of Fos, interleukin-1beta and inducible nitric oxide synthase in rat brain.
|
Academic Article
|
Phosphatidylinositol 3'-kinase, but not S6-kinase, is required for insulin-like growth factor-I and IL-4 to maintain expression of Bcl-2 and promote survival of myeloid progenitors.
|
Academic Article
|
Increased sensitivity of prediabetic nonobese diabetic mouse to the behavioral effects of IL-1.
|
Academic Article
|
Endogenous brain IL-1 mediates LPS-induced anorexia and hypothalamic cytokine expression.
|
Academic Article
|
Diffusion and action of intracerebroventricularly injected interleukin-1 in the CNS.
|
Academic Article
|
Role of interleukin-1beta and tumour necrosis factor-alpha in lipopolysaccharide-induced sickness behaviour: a study with interleukin-1 type I receptor-deficient mice.
|
Academic Article
|
Cytokine signals propagate through the brain.
|
Academic Article
|
Vagotomy attenuates the behavioural but not the pyrogenic effects of interleukin-1 in rats.
|
Academic Article
|
Rat microglial cells secrete predominantly the precursor of interleukin-1beta in response to lipopolysaccharide.
|
Academic Article
|
Dual effect of central injection of recombinant rat interleukin-4 on lipopolysaccharide-induced sickness behavior in rats.
|
Academic Article
|
Insulin-like growth factor-I and the cytokines IL-3 and IL-4 promote survival of progenitor myeloid cells by different mechanisms.
|
Academic Article
|
Chronic mild stress in mice decreases peripheral cytokine and increases central cytokine expression independently of IL-10 regulation of the cytokine network.
|
Academic Article
|
Importance of fighting in the immune effects of social defeat.
|
Academic Article
|
Innate immunity at the forefront of psychoneuroimmunology.
|
Academic Article
|
Influence of the course of brain inflammation on the endogenous IL-1beta/IL-1Ra balance in the model of brain delayed-type hypersensitivity response to bacillus Calmette-Gu?rin in Lewis rats.
|
Academic Article
|
Baseline mood and psychosocial characteristics of patients developing depressive symptoms during interleukin-2 and/or interferon-alpha cancer therapy.
|
Academic Article
|
Chronic administration of tianeptine balances lipopolysaccharide-induced expression of cytokines in the spleen and hypothalamus of rats.
|
Academic Article
|
IL-1beta suppresses prolonged Akt activation and expression of E2F-1 and cyclin A in breast cancer cells.
|
Academic Article
|
Immune alterations induced by social defeat do not alter the course of an on-going BCG infection in mice.
|
Academic Article
|
NFkappaB activates in vivo the synthesis of inducible Cox-2 in the brain.
|
Academic Article
|
In vitro and in vivo evidence for a role of the P2X7 receptor in the release of IL-1 beta in the murine brain.
|
Academic Article
|
Uncoupling of interleukin-6 from its signalling pathway by dietary n-3-polyunsaturated fatty acid deprivation alters sickness behaviour in mice.
|
Academic Article
|
Fractalkine receptor (CX3CR1) deficiency sensitizes mice to the behavioral changes induced by lipopolysaccharide.
|
Academic Article
|
The associations of adiposity, physical activity and inflammation with fatigue in older adults.
|
Academic Article
|
Modulation of the behavioural effects of interleukin-1 in mice by nitric oxide.
|
Academic Article
|
Androgen-dependent vasopressinergic neurotransmission attenuates interleukin-1-induced sickness behavior.
|
Academic Article
|
[Dissociation between peripheral and central components of tolerance to behavior effects of interleukin-1 in rats].
|
Academic Article
|
Subdiaphragmatic vagotomy blocks induction of IL-1 beta mRNA in mice brain in response to peripheral LPS.
|
Academic Article
|
Defect in interleukin-1beta secretion prevents sickness behavior in C3H/HeJ mice.
|
Academic Article
|
Central interleukin-1 receptors as mediators of sickness.
|
Academic Article
|
The immune-endocrine loop during aging: role of growth hormone and insulin-like growth factor-I.
|
Academic Article
|
Central administration of rat IL-6 induces HPA activation and fever but not sickness behavior in rats.
|
Academic Article
|
IL-10 promotes survival of microglia without activating Akt.
|
Academic Article
|
Cytokine-induced sickness behavior: mechanisms and implications.
|
Academic Article
|
Tumor necrosis factor alpha inhibits insulin-like growth factor I-induced hematopoietic cell survival and proliferation.
|
Academic Article
|
Signaling pathways of interleukin-1 actions in the brain: anatomical distribution of phospho-ERK1/2 in the brain of rat treated systemically with interleukin-1beta.
|
Academic Article
|
Effects of insulin-like growth factor-I on cytokine-induced sickness behavior in mice.
|
Academic Article
|
Prototypical anti-inflammatory cytokine IL-10 prevents loss of IGF-I-induced myogenin protein expression caused by IL-1beta.
|
Academic Article
|
Central nervous action of interleukin-1 mediates activation of limbic structures and behavioural depression in response to peripheral administration of bacterial lipopolysaccharide.
|
Academic Article
|
G protein-coupled receptor kinase 6 acts as a critical regulator of cytokine-induced hyperalgesia by promoting phosphatidylinositol 3-kinase and inhibiting p38 signaling.
|
Academic Article
|
Mechanisms of the behavioral effects of interleukin 1. Role of prostaglandins and CRF.
|
Academic Article
|
Pyrogens specifically disrupt the acquisition of a task involving cognitive processing in the rat.
|
Academic Article
|
Lowered serum dipeptidyl peptidase IV activity is associated with depressive symptoms and cytokine production in cancer patients receiving interleukin-2-based immunotherapy.
|
Academic Article
|
Dexamethasone up-regulates type II IL-1 receptor in mouse primary activated astrocytes.
|
Academic Article
|
Conditioned place aversion with interleukin-1beta in mice is not associated with activation of the cytokine network.
|
Academic Article
|
Putative neuroprotective and neurotoxic kynurenine pathway metabolites are associated with hippocampal and amygdalar volumes in subjects with major depressive disorder.
|
Academic Article
|
CRF is not involved in the behavioral effects of peripherally injected interleukin 1 in the rat
|
Academic Article
|
Rat microglial cells secrete predominantly the precursor of interleukin-1β in response to lipopolysaccharide
|
Academic Article
|
Interleukin-1 receptor antagonist blocks effects of IL-1α and IL-1β on social behaviour and body weight in mice
|
Academic Article
|
Aversive effects of centrally injected interleukin-1
|
Academic Article
|
Upregulation of neuronal kynurenine 3-monooxygenase mediates depression-like behavior in a mouse model of neuropathic pain.
|
Academic Article
|
Tumor-Associated Fatigue in Cancer Patients Develops Independently of IL1 Signaling.
|
Academic Article
|
Resolution of inflammation-induced depression requires T lymphocytes and endogenous brain interleukin-10 signaling.
|
Academic Article
|
Protocol for the insight study: a randomised controlled trial of single-dose tocilizumab in patients with depression and low-grade inflammation.
|
Academic Article
|
Interleukin-1 reduces food intake and body weight in rat by acting in the arcuate hypothalamus.
|
Academic Article
|
Interleukin-10 resolves pain hypersensitivity induced by cisplatin by reversing sensory neuron hyperexcitability.
|
Academic Article
|
Interleukin 6-independent metabolic reprogramming as a driver of cancer-related fatigue.
|
Academic Article
|
Interleukin-6 as potential mediator of long-term neuropsychiatric symptoms of COVID-19.
|
Academic Article
|
Neutralizing interleukin-6 in tumor-bearing mice does not abrogate behavioral fatigue induced by Lewis lung carcinoma.
|
Academic Article
|
Brain Perivascular Macrophages Do Not Mediate Interleukin-1-Induced Sickness Behavior in Rats.
|
Academic Article
|
Effects of placebo administration on immune mechanisms and relationships with central endogenous opioid neurotransmission.
|
Academic Article
|
Resolution of cisplatin-induced fatigue does not require endogenous interleukin-10 in male mice.
|
Academic Article
|
Tonic Meningeal Interleukin-10 Upregulates Delta Opioid Receptor to Prevent Relapse to Pain.
|